DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Kallikrein
Kallikrein
Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
Studies on a Complex Mechanism for the Activation of Plasminogen by Kaolin and by Chloroform: the Participation of Hageman Factor and Additional Cofactors
Download, Or Email Articles for Individual Use
Activation of the Plasma Kallikrein-Kinin System in Respiratory Distress Syndrome
Assessing Plasmin Generation in Health and Disease
The Characteristic Normalization of the Severely Prolonged Aptt Following Increased Preincubation Time Is Due to Autoactivation of Factor XII
Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis
The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis
The Molecular Basis of Blood Coagulation Review
Activation of Human Factor VII in Plasma and in Purified Systems
Activation of the Classical Pathway of Complement by Hageman Factor Fragment*
Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease
Kallikrein Directly Interacts with and Activates Factor IX, Resulting in Thrombin Generation and Fibrin Formation Independent of Factor XI
Kallikrein Inhibitors1
Kallikrein Directly Interacts with and Activates Factor IX, Resulting in Thrombin Generation and Fibrin Formation Independent of Factor XI
Activation of the Factor XII-Driven Contact System in Alzheimerts
14 Responses by Kallikrein-Related Peptidase Induction of Complement
The Plasma Kallikrein-Kinin System Counterbalances the Renin- Angiotensin System
Top View
Thrombin-Like Enzymes in Snake Venoms
New Insights on Moojase, a Thrombin-Like Serine Protease from Bothrops Moojeni Snake Venom
Plasma Contact Activation: a Revised Hypothesis
PREKALLIKREIN · C1 INHIBITOR Monday
Factor XII Kallikrein and Kininogen
Coagulation Factor XII in Thrombosis and Inflammation
Nomenclature of Factor XI and the Contact System
Blood Coagulation Wound Healing
Blood Coagulation Factor Xia Binds Specifically to a Site on Activated Human Platelets Distinct from That for Factor XI
Studies of Binding of Prekallikrein and Factor XI to High Molecular Weight Kininogen and Its Light Chain
(12) United States Patent (10) Patent No.: US 9,593,339 B1 Bermudes (45) Date of Patent: Mar
Activation of Factor B of the Complement System by Kallikrein Amd Its Light Chain
Regulation of Fibrinolysis and Coagulation
Kallikrein-Kinin Blockade in Patients with COVID-19 to Prevent Acute
DIRECT EVIDENCE, USING Pro-Phe-Argch2cl, THAT PLASMA KALLIKREIN HAS a ROLE in ACID ACTIVATION of INACTIVE RENIN in PLASMA from NORMAL SUBJECTS
Kallikrein and Its Activation in Experimental Trypanosoma Brucei Infections of Rabbits
Activation of the Plasma Clotting, Fibrinolytic, and Kinin-Kallikrein System in Preterm Infants with Severe Idiopathic Respiratory Distress Syndrome
Expression of Cdna for Batroxobin, a Thrombin-Like Snake Venom Enzyme
Proteolytic Activation of Tissue Plasminogen Activator by Plasma and Tissue Enzymes
Chromogenix Research Methods Urine Kallikrein
Role of Factor Xia and Plasma Kallikrein in Arterial and Venous Thrombosis